The collaboration will pave the way for development of a real world research platform to facilitate evidence generation in type 1 diabetes for multiple stakeholders.
The European Foundation for the Study of Diabetes (EFSD), JDRF and Eli Lilly and Company (NYSE: LLY) have agreed to extend their collaboration for the European Programme in Type 1 Diabetes Research through 2020